GlassScriptPhysician profile
Alicia Crooks
NPI 1831354919
$5,310.64
in general payments reported to CMS, 2019-2025
17 companies · $611 in 2025
The $611 reported for 2025 was more than what 82% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $442 · 2021: $425 · 2022: $2,560 · 2023: $611 · 2024: $176 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Entertainment: $170 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.64 |
| Entertainment | $169.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,025.00 | 2022 | |
| Alcon Vision LLC | $699.74 | 2019-2025 | Precision7 |
| Allergan, INC. | $402.16 | 2019-2022 | |
| Abbvie INC. | $364.44 | 2023-2025 | Vuity |
| Biotissue Holdings INC. | $270.95 | 2025 | |
| Mallinckrodt Hospital Products INC. | $224.99 | 2022-2023 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $214.84 | 2019 | |
| Optos, INC. | $169.87 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Rxsight INC | $136.43 | 2022 | |
| Sun Pharmaceutical Industries INC. | $125.00 | 2022 | |
| Kala Pharmaceuticals, INC. | $124.46 | 2021 | |
| Sight Sciences, INC. | $120.54 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $120.43 | 2024 | Xdemvy |
| Glaukos Corporation | $90.29 | 2023 | |
| Oyster Point Pharma, INC. | $80.13 | 2022-2023 | Tyrvaya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $72.28 | 2020 | |
| Novartis Pharmaceuticals Corporation | $69.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alicia Crooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.